MANAC Chemical Partners Co.,Ltd AI Stock Analysis
Want to see JP:4360 full AI Analyst Report?
MANAC Chemical Partners Co.,Ltd (4360) AI Stock Analysis
MANAC Chemical Partners Co.,Ltd
(TSE/TYO:4360)
The score is primarily driven by improved financial performance and a conservative balance sheet alongside an attractive low P/E. Offsetting these positives are meaningful historical volatility in earnings/cash flow and a mixed technical picture with negative MACD and the price below near-term moving averages.
MANAC Chemical Partners Co.,Ltd (4360) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 8.17B
- Dividend Yield
- 1.52%
- Average Volume (3M)
- 7,183
- Price to Earnings (P/E)
- 8.2
- Beta (1Y)
- 0.97
- Revenue Growth
- 19.58%
- EPS Growth
- ―
- Country
- Japan
- Employees
- 246
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Chemicals
MANAC Chemical Partners Co.,Ltd Business Overview & Revenue Model
Company Description
Operating primarily in Japan, MANAC Chemical Partners Co.,Ltd, along with its subsidiaries, undertakes the comprehensive development, manufacturing, sales, import, and export of industrial chemicals and pharmaceutical products. The company additional...
How the Company Makes Money
MANAC Chemical Partners makes money primarily by selling chemical products it manufactures to business customers (B2B). Revenue is generated through (1) product sales of specialty/fine chemicals (including functional materials and chemical intermedia...
MANAC Chemical Partners Co.,Ltd Financial Statement Overview
Summary
Fundamentals show a strong 2026 rebound: revenue growth (+14.5%), return to solid profitability, and operating/free cash flow turning positive. The balance sheet remains conservative with low debt versus equity. The main offset is high earnings and cash flow volatility across 2024–2026 (including a large net loss in 2025), which reduces confidence in sustainability.
Income Statement
70PositiveBalance Sheet
83Very PositiveCash Flow
67Positive| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.48B | 10.99B | 9.30B | 9.69B | 11.85B | 10.70B |
| Gross Profit | 2.85B | 2.50B | 1.47B | 1.82B | 2.81B | 2.43B |
| EBITDA | 1.50B | 1.11B | -312.00M | 545.00M | 1.62B | 1.19B |
| Net Income | 983.00M | 781.00M | -895.00M | 82.00M | 821.00M | 712.00M |
Balance Sheet | ||||||
| Total Assets | 16.02B | 15.31B | 12.65B | 14.10B | 15.01B | 13.59B |
| Cash, Cash Equivalents and Short-Term Investments | 4.19B | 4.01B | 2.77B | 3.29B | 3.72B | 2.04B |
| Total Debt | 791.00M | 816.00M | 0 | 0 | 290.00M | 291.00M |
| Total Liabilities | 4.32B | 4.00B | 2.34B | 2.85B | 3.97B | 3.29B |
| Stockholders Equity | 11.70B | 11.30B | 10.30B | 11.25B | 11.04B | 10.29B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 531.00M | -411.00M | -593.00M | 1.40B | 30.00M |
| Operating Cash Flow | 0 | 2.15B | 108.00M | -118.00M | 1.65B | 714.00M |
| Investing Cash Flow | 0 | -1.66B | -489.00M | -231.00M | 199.00M | -422.00M |
| Financing Cash Flow | 0 | 727.00M | -126.00M | -75.00M | -125.00M | -200.00M |
MANAC Chemical Partners Co.,Ltd Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4360, the sentiment is Positive. The current price of 984.00 is above the 20-day moving average (MA) of 978.10, above the 50-day MA of 981.11, and above the 200-day MA of 902.32, indicating a bullish trend. The MACD of -4.89 indicates Positive momentum. The RSI at 52.35 is Neutral, neither overbought nor oversold. The STOCH value of 81.23 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4360.
MANAC Chemical Partners Co.,Ltd Peers Comparison
Overall Rating
JP:404079Outperform
JP:656873Outperform
JP:436071Outperform
JP:453159Neutral
JP:496059Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 79Outperform | JPY 9.44B | 2.70 | ― | 1.61% | 0.56% | 238.99% | |
| 73Outperform | JPY 9.15B | 11.24 | ― | 2.78% | 12.39% | 22.04% | |
| 71Outperform | JPY 8.33B | 8.16 | ― | 1.52% | 19.58% | ― | |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 59Neutral | JPY 7.27B | 14.81 | ― | 3.05% | 3.90% | -31.32% | |
| 59Neutral | JPY 8.48B | 21.11 | ― | 0.97% | 6.87% | 300.65% |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:4360 | MANAC Chemical Partners Co.,Ltd | 984.00 | 346.05 | 54.24% | |
| JP:4040 | NANKAI CHEMICAL COMPANY LIMITED | 4040.00 | 1044.45 | 34.87% | |
| JP:4531 | Yuki Gosei Kogyo Co., Ltd. | 328.00 | 52.96 | 19.26% | |
| JP:4960 | Chemipro Kasei Kaisya,Ltd. | 491.00 | 167.43 | 51.75% | |
| JP:6568 | KNC Laboratories Co.,Ltd. | 1189.00 | 102.09 | 9.39% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 12, 2026
